Evoke Pharma Inc.

Evoke Pharma Inc. is a specialty pharmaceutical company committed to the development and commercialization of drugs designed to treat gastrointestinal (GI) disorders. With a primary focus on unmet medical needs, Evoke's flagship product is centered around the treatment of diabetic gastroparesis, a chronic condition that affects gastric motility. By addressing niche therapeutic areas, Evoke Pharma contributes to improving patient quality of life through innovative treatment options. The company operates within the broader healthcare sector, directly impacting the pharmaceutical industry by pioneering specific solutions that cater to both patients and healthcare providers. Established in Solana Beach, California, Evoke Pharma plays a significant role in the ongoing efforts to enhance therapeutic interventions for digestive health issues, fostering collaborations with research institutions and regulatory bodies. The company's dedication to addressing specific health conditions underscores its importance in the niche markets of the pharmaceutical landscape, both in the United States and internationally.